Latest News & Features
Big Pharma
The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. 9 November 2017
Biotechnology
In September 2016, the German Federal Supreme Court decided a patent case that could have a major impact on companies working in the diagnostics field. Joachim Wachenfeld of Vossius & Partner reports. 9 November 2017
Americas
Past successes by trailblazers in other biotechnological fields could assist potential patentees navigate legal bumps along the road to IP protection for CRISPR-related inventions, as Patricia Carson and Ashley Ross of Kirkland & Ellis describe. 9 November 2017
Big Pharma
Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court. 8 November 2017
Americas
The US Court of Appeals for the Federal Circuit has backed a ruling by the US Patent and Trademark Office which invalidated a patent owned by the University of Maryland Biotechnology Institute. 8 November 2017
Big Pharma
Switzerland-based Roche has confirmed it will provide a cancer drug free of charge after an altercation with the Greek government. 7 November 2017
Americas
Cindy Ahn, a former counsel at Schiff Hardin, has joined private equity firm Longford Capital to help handle demand for litigation finance among life sciences and biotech firms. 6 November 2017
Americas
Pharmaceutical companies have entered into fewer potential ‘pay-for-delay’ patent settlements for the second year in a row, following the US Supreme Court’s decision in FTC v Actavis. 6 November 2017
Americas
A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity. 6 November 2017
Americas
Biopharmaceutical company Sarepta Therapeutics is exploring the potential of CRISPR/Cas9 gene editing technology to treat Duchenne muscular dystrophy (DMD). 3 November 2017